Beclomethasone: Advanced Anti-Inflammatory Relief for Respiratory Conditions
Cialis
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.00 | $40.00 (0%) | 🛒 Add to cart |
| 20 | $2.75 | $80.00 $55.00 (31%) | 🛒 Add to cart |
| 30 | $2.33 | $120.00 $70.00 (42%) | 🛒 Add to cart |
| 60 | $1.83 | $240.00 $110.00 (54%) | 🛒 Add to cart |
| 90 | $1.78 | $360.00 $160.00 (56%) | 🛒 Add to cart |
| 120 | $1.58 | $480.00 $190.00 (60%) | 🛒 Add to cart |
| 180 | $1.39 | $720.00 $250.00 (65%) | 🛒 Add to cart |
| 270 | $1.22 | $1080.00 $330.00 (69%) | 🛒 Add to cart |
| 360 | $1.11
Best per pill | $1440.00 $400.00 (72%) | 🛒 Add to cart |
| Product dosage: 2.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.50 | $45.00 (0%) | 🛒 Add to cart |
| 60 | $1.33 | $90.00 $80.00 (11%) | 🛒 Add to cart |
| 90 | $1.22 | $135.00 $110.00 (19%) | 🛒 Add to cart |
| 120 | $1.17 | $180.00 $140.00 (22%) | 🛒 Add to cart |
| 180 | $0.89 | $270.00 $160.00 (41%) | 🛒 Add to cart |
| 270 | $0.78 | $405.00 $210.00 (48%) | 🛒 Add to cart |
| 360 | $0.68
Best per pill | $540.00 $245.00 (55%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.50 | $45.00 (0%) | 🛒 Add to cart |
| 20 | $3.25 | $90.00 $65.00 (28%) | 🛒 Add to cart |
| 30 | $2.83 | $135.00 $85.00 (37%) | 🛒 Add to cart |
| 60 | $2.50 | $270.00 $150.00 (44%) | 🛒 Add to cart |
| 90 | $2.22 | $405.00 $200.00 (51%) | 🛒 Add to cart |
| 120 | $2.08 | $540.00 $250.00 (54%) | 🛒 Add to cart |
| 180 | $1.67 | $810.00 $300.00 (63%) | 🛒 Add to cart |
| 270 | $1.41 | $1215.00 $380.00 (69%) | 🛒 Add to cart |
| 360 | $1.31
Best per pill | $1620.00 $470.00 (71%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.25 | $45.00 (0%) | 🛒 Add to cart |
| 30 | $2.00 | $67.50 $60.00 (11%) | 🛒 Add to cart |
| 60 | $1.50 | $135.00 $90.00 (33%) | 🛒 Add to cart |
| 90 | $1.44 | $202.50 $130.00 (36%) | 🛒 Add to cart |
| 120 | $1.25 | $270.00 $150.00 (44%) | 🛒 Add to cart |
| 180 | $1.11 | $405.00 $200.00 (51%) | 🛒 Add to cart |
| 270 | $0.96 | $607.50 $260.00 (57%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $810.00 $315.00 (61%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Beclomethasone is a potent corticosteroid medication designed to manage and prevent inflammation in respiratory conditions. As an inhaled glucocorticoid, it delivers targeted anti-inflammatory action directly to the lungs and airways with minimal systemic absorption. This medication represents a cornerstone in maintenance therapy for asthma and other inflammatory respiratory disorders, offering patients improved symptom control and enhanced quality of life. Clinical evidence supports its efficacy in reducing airway hyperresponsiveness and preventing exacerbations.
Features
- Potent glucocorticoid receptor agonist with high local anti-inflammatory activity
- Available in metered-dose inhaler (MDI), dry powder inhaler (DPI), and nasal spray formulations
- Microfine particle technology for optimal lung deposition
- Hydrofluoroalkane (HFA) propellant in modern formulations (ozone-friendly)
- Typically administered twice daily for maintenance therapy
- Rapid onset of action with effects noticeable within 24-72 hours of initiation
- Compatible with spacer devices for improved drug delivery
Benefits
- Significantly reduces airway inflammation and mucosal edema
- Decreases frequency and severity of asthma exacerbations
- Improves lung function parameters (FEV1, PEFR)
- Reduces reliance on rescue bronchodilators
- Enhances overall asthma control and quality of life
- Minimizes systemic corticosteroid exposure compared to oral formulations
- Prevents exercise-induced bronchoconstriction when used prophylactically
Common use
Beclomethasone is primarily indicated for the prophylactic management of persistent asthma in patients aged 5 years and older. It is also approved for the treatment of allergic rhinitis when administered via nasal spray formulation. Off-label uses include management of chronic obstructive pulmonary disease (COPD) with an inflammatory component, prevention of nasal polyps recurrence post-surgery, and treatment of eosinophilic esophagitis in certain clinical scenarios. The medication is not intended for relief of acute bronchospasm but rather for long-term inflammatory control.
Dosage and direction
Asthma Management (Inhalation):
- Adults: 40-320 mcg twice daily (initial dose depends on disease severity)
- Children (5-11 years): 40-80 mcg twice daily
- Maximum daily dose: 640 mcg in divided doses for adults
Allergic Rhinitis (Nasal Spray):
- Adults and children ≥12 years: 1-2 sprays per nostril twice daily (42-168 mcg per nostril daily)
- Children 6-11 years: 1 spray per nostril twice daily (84 mcg daily)
Administration technique is critical for optimal efficacy. For inhalers: shake well, exhale completely, position inhaler correctly, activate while inhaling slowly and deeply, hold breath for 5-10 seconds. Rinse mouth after inhalation to reduce candidiasis risk. Nasal spray: prime before first use, insert tip into nostril, direct spray away from nasal septum, breathe gently inward.
Precautions
Patients should be monitored for decreased bone mineral density with long-term use, particularly postmenopausal women and those with other osteoporosis risk factors. Regular ophthalmologic examinations are recommended to monitor for cataracts and glaucoma. Growth velocity should be monitored in pediatric patients. Caution required in patients with active or quiescent tuberculosis infections, fungal, bacterial, or viral infections, or ocular herpes simplex. Systemic effects may occur at high doses, particularly with improper inhalation technique. Patients should not discontinue abruptly if using long-term.
Contraindications
Beclomethasone is contraindicated in patients with known hypersensitivity to beclomethasone dipropionate or any component of the formulation. Not recommended for primary treatment of status asthmaticus or other acute episodes where intensive measures are required. Contraindicated in untreated fungal, bacterial, or viral respiratory infections. Should not be used for nasal conditions with recent nasal surgery or trauma until healing has occurred.
Possible side effect
Common (≥1%):
- Oropharyngeal candidiasis (5-15%)
- Hoarseness or dysphonia (5-10%)
- Throat irritation (3-8%)
- Cough following inhalation (2-5%)
- Headache (2-4% with nasal formulation)
Less common (<1%):
- Nasal septum perforation (nasal spray)
- Epistaxis
- Bronchospasm (paradoxical)
- Allergic contact dermatitis
- Growth suppression in children
- Adrenal suppression (high doses)
- Cataracts or glaucoma
- Osteoporosis
Rare (<0.1%):
- Anaphylaxis
- Eosinophilic conditions
- Hypercorticism
- Psychological effects including anxiety and depression
Drug interaction
Beclomethasone may interact with strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) potentially increasing systemic exposure. Concurrent use with other corticosteroids (oral, nasal, inhaled) may increase risk of hypothalamic-pituitary-adrenal (HPA) axis suppression. Diuretics may enhance hypokalemic effects. Concomitant use with non-potassium sparing diuretics may increase risk of hypokalemia. May reduce effectiveness of vaccinations; live vaccines should be avoided during high-dose therapy.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed administration. Consistent daily use is important for optimal inflammatory control, but occasional missed doses are unlikely to significantly affect overall control if the regular schedule is promptly resumed.
Overdose
Acute overdose is unlikely to produce life-threatening symptoms due to the local action and limited bioavailability. However, chronic excessive use may lead to systemic corticosteroid effects including hypercorticism, adrenal suppression, growth suppression in children, and other corticosteroid-related adverse effects. Treatment should be supportive and symptomatic. In cases of significant systemic absorption, monitoring of adrenal function may be necessary. There is no specific antidote; dose reduction or temporary discontinuation may be required.
Storage
Store at room temperature (15-30°C/59-86°F) away from light and moisture. Do not freeze. Keep the canister away from heat and open flames (may burst if heated). Do not puncture or incinerate. Nasal spray should be stored with the protective cap on. Keep tightly closed when not in use. For inhalers: discard after labeled number of actuations has been used, as subsequent doses may not contain the correct amount of medication. Keep out of reach of children.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Individual patient needs may vary. Always consult with a qualified healthcare professional before starting or changing any medication regimen. The prescribing physician should be aware of the patient’s complete medical history and current medications. Proper diagnosis and monitoring are essential for safe and effective use. Not all possible uses, interactions, or adverse effects are listed here.
Reviews
Clinical Evidence Summary: Multiple randomized controlled trials demonstrate beclomethasone significantly improves asthma control compared to placebo. A meta-analysis of 25 studies (n=4,328) showed 60% reduction in exacerbation rates. Pediatric studies demonstrate improved growth parameters compared to oral corticosteroids. Real-world evidence confirms maintenance of lung function and reduced healthcare utilization.
Expert Consensus: Pulmonary specialists regard beclomethasone as a well-established, cost-effective option for mild-to-moderate persistent asthma. The Global Initiative for Asthma (GINA) guidelines recommend inhaled corticosteroids like beclomethasone as first-line controller therapy. The medication’s safety profile is considered favorable when used at appropriate doses with proper technique.
Patient Reported Outcomes: Surveys indicate 78% of patients report improved symptom control within 2 weeks of initiation. Quality of life scores show significant improvement in domains of physical function and symptom burden. Adherence challenges noted primarily related to device technique rather than medication effects.